The new facility will double its existing footprint, and support development, clinical and small-scale commercial manufacturing. The site is just a few miles from its current office, and will meet all FDA, EMA and GMP requirements, the company said.
Friday, June 4, 2021
AavantiBio lands manufacturing partner in Friedreich's Ataxia program; NC Research Triangle lands another CDMO
June 3, 2021. ENDPOINTNEWS. AavantiBio and Resilience have announced a collaboration to manufacture a pipeline of therapies, including AavantiBio’s Friedreich’s Ataxia program, the company announced Thursday.
Subscribe to:
Posts (Atom)
